Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate.
Von Dadelszen
P
P
Hurst
P R
PR
Peplow
P V
PV
D000830:Animals, Laboratory; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003933:Diagnosis; D004703:Endocrine System; D005193:Family Planning Services; D013502:General Surgery; D005835:Genitalia; D005836:Genitalia, Female; D006728:Hormones; D007434:Intrauterine Devices; D007436:Intrauterine Devices, Medicated; D007813:Laparotomy; D017258:Medroxyprogesterone Acetate; D009215:Myometrium; D010827:Physiology; D011374:Progesterone; D011372:Progestins; D012106:Research; D012153:Retention, Psychology; D013812:Therapeutics; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D011372:Progestins; D011374:Progesterone; D017258:Medroxyprogesterone Acetate
Animals, Laboratory; Biology; Clinical Research; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Endocrine System; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Hormones; Iud; Iud, Hormone Releasing; Laparotomy; Medroxyprogesterone Acetate; Myometrial Effects; Myometrium; Physiology; Progestational Hormones; Progesterone; Research Methodology; Retention--statistics; Surgery; Treatment; Urogenital System; Uterus